Equities

T2 Biosystems Inc

T2 Biosystems Inc

Actions
  • Price (EUR)0.484
  • Today's Change0.000 / 0.00%
  • Shares traded620.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 07:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments161032
Total Receivables, Net1.422.165.13
Total Inventory4.824.293.91
Prepaid expenses3.262.583.11
Other current assets, total------
Total current assets251944
Property, plant & equipment, net9.051314
Goodwill, net------
Intangibles, net------
Long term investments----0
Note receivable - long term------
Other long term assets0.000.140.15
Total assets353461
LIABILITIES
Accounts payable1.531.302.83
Accrued expenses118.628.34
Notes payable/short-term debt4100
Current portion long-term debt/capital leases------
Other current liabilities, total2.010.210.52
Total current liabilities561012
Total long term debt05048
Total debt415048
Deferred income tax------
Minority interest------
Other liabilities, total6.681414
Total liabilities637473
SHAREHOLDERS EQUITY
Common stock0.000.010.17
Additional paid-in capital556495459
Retained earnings (accumulated deficit)(584)(534)(472)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total----0.00
Total equity(28)(40)(13)
Total liabilities & shareholders' equity353461
Total common shares outstanding4.060.080.03
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.